Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome

Jaroslav A. Hubáček(Institute of Clinical and Experimental Medicine), Jan Piťha(Centre of Civil Engineering (Czechia)), Petr Hájek(University Hospital in Motol), R. Poledne(Institute of Clinical and Experimental Medicine), Věra Lánská(Institute of Clinical and Experimental Medicine), Josef Veselka(University Hospital Kralovske Vinohrady), M Gebauerová(Institute of Clinical and Experimental Medicine), Jana Matoušková(General University Hospital in Prague), Martin Pěnička, Hana Skalická(University of Iowa), Hana Hrabáková(University Hospital Kralovske Vinohrady), V. Staněk(Institute of Clinical and Experimental Medicine), Věra Adámková(Institute of Clinical and Experimental Medicine), A. Krüger(Na Homolce Hospital), Michael Aschermann
Molecular Biology Reports
March 25, 2015
10.1007/s11033-015-3870-1
Cited by 17

Related Papers

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|The Lancet|2014|709
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
|BMJ|2014|677
Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest
|JAMA|2022|674
Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study
|European Heart Journal - Cardiovascular Imaging|2017|348
Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study
|European Heart Journal - Cardiovascular Imaging|2018|336